Warning: Illegal string offset 'name' in /homepages/29/d231077926/htdocs/review/wp-content/plugins/genesis-simple-sidebars/plugin.php on line 105

Warning: Illegal string offset 'description' in /homepages/29/d231077926/htdocs/review/wp-content/plugins/genesis-simple-sidebars/plugin.php on line 107
Press Release — Augmenix

Augmenix Receives CE Mark Approval for TraceIT® Fiducial Marker and TraceIT® Gel System

Waltham, Massachusetts November 5, 2013: Augmenix, Inc. today announced that it has received European commercial approval for both TraceIT Fiducial Marker and TraceIT Gel System, absorbable markers visible under CT, MR, cone beam and ultrasound imaging modalities.  The TraceIT Fiducial Marker (1 mL) is indicated as an absorbable fiducial marker, while the TraceIT Gel System […]

Augmenix Receives FDA Clearance to Market its TraceIT™ Tissue Marker

Waltham, Massachusetts January 28, 2013: Augmenix, Inc., an innovative medical technology company focused on utilizing hydrogel technology in the fields of tissue marking and radiation oncology, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its TraceIT Tissue Marker, an absorbable tissue marker visible under CT, […]

Varian Medical Systems Makes Equity Investment and Obtains Option to Purchase Augmenix

Agreement creates opportunity for improving outcomes in radiation oncology PALO ALTO, Calif. and WALTHAM, Mass., May 12, 2011 /PRNewswire/ — Varian Medical Systems, Inc. (NYSE: VAR), the world’s leading supplier of medical technology for treating cancer with radiotherapy, and privately-held Augmenix, Inc. today announced that they have reached an agreement under which Varian will make […]

Augmenix Announces First Commercial Use of SpaceOAR™ System

Augmenix Announces First Commercial Use of SpaceOAR™ System for Prostate-Rectum Separation in Prostate Cancer Patients Undergoing Radiation Therapy WALTHAM, Mass., Aug. 11 /PRNewswire/ — Augmenix, Inc. announced today that Prof. Michael Eble and Dr. Michael Pinkawa of the Aachen University Hospital, Aachen, Germany, performed a commercial implantation of the company’s CE Mark approved SpaceOAR™ System. […]

Augmenix Inc.’s polymers for radiation

By MassDevice Created 10/02/2009 – 11:14 The Waltham, Mass.-based firm is developing polymerized biomaterials to help improve cancer radiation treatments. View entire article…